⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LTRN News
Lantern Pharma Inc. Common Stock
Lantern Pharma Presents LP-284 Clinical Data at 25 th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
businesswire.com
LTRN
LTRN
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
businesswire.com
LTRN
LTRN
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
ENLV
LTRN
LTRN